» Articles » PMID: 33794877

CREB-dependent LPA-induced Signaling Initiates a Pro-fibrotic Feedback Loop Between Small Airway Basal Cells and Fibroblasts

Overview
Journal Respir Res
Specialty Pulmonary Medicine
Date 2021 Apr 2
PMID 33794877
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Lysophosphatidic acid (LPA), generated extracellularly by the action of autotaxin and phospholipase A2, functions through LPA receptors (LPARs) or sphingosine-1-phosphate receptors (S1PRs) to induce pro-fibrotic signaling in the lower respiratory tract of patients with idiopathic pulmonary fibrosis (IPF). We hypothesized that LPA induces changes in small airway epithelial (SAE) basal cells (BC) that create cross-talk between the BC and normal human lung fibroblasts (NHLF), enhancing myofibroblast formation.

Methods: To assess LPA-induced signaling, BC were treated with LPA for 2.5 min and cell lysates were analyzed by phosphokinase array and Western blot. To assess transcriptional changes, BC were treated with LPA for 3 h and harvested for collection and analysis of RNA by quantitative polymerase chain reaction (qPCR). To assess signaling protein production and function, BC were washed thoroughly after LPA treatment and incubated for 24 h before collection for protein analysis by ELISA or functional analysis by transfer of conditioned medium to NHLF cultures. Transcription, protein production, and proliferation of NHLF were assessed.

Results: LPA treatment induced signaling by cAMP response element-binding protein (CREB), extracellular signal-related kinases 1 and 2 (Erk1/2), and epithelial growth factor receptor (EGFR) resulting in elevated expression of connective tissue growth factor (CTGF), endothelin-1 (EDN1/ET-1 protein), and platelet derived growth factor B (PDGFB) at the mRNA and protein levels. The conditioned medium from LPA-treated BC induced NHLF proliferation and increased NHLF expression of collagen I (COL1A1), smooth muscle actin (ACTA2), and autotaxin (ENPP2) at the mRNA and protein levels. Increased autotaxin secretion from NHLF correlated with increased LPA in the NHLF culture medium. Inhibition of CREB signaling blocked LPA-induced changes in BC transcription and translation as well as the pro-fibrotic effects of the conditioned medium on NHLF.

Conclusion: Inhibition of CREB signaling may represent a novel target for alleviating the LPA-induced pro-fibrotic feedback loop between SAE BC and NHLF.

Citing Articles

Bronchopulmonary dysplasia demonstrates dysregulated autotaxin/lysophosphatidic acid signaling in a neonatal mouse model.

Ha A, Sudhadevi T, Jafri A, Mayer C, MacFarlane P, Natarajan V Pediatr Res. 2024; .

PMID: 39415037 DOI: 10.1038/s41390-024-03610-9.


Connective tissue growth factor: Role in trabecular meshwork remodeling and intraocular pressure lowering.

Hassan M, Razali N, Bakar A, Abu Hanipah N, Agarwal R Exp Biol Med (Maywood). 2023; 248(16):1425-1436.

PMID: 37873757 PMC: 10657592. DOI: 10.1177/15353702231199466.


Lipid metabolism in idiopathic pulmonary fibrosis: From pathogenesis to therapy.

Chen R, Dai J J Mol Med (Berl). 2023; 101(8):905-915.

PMID: 37289208 DOI: 10.1007/s00109-023-02336-1.


Lysophosphatidic Acid Is a Proinflammatory Stimulus of Renal Tubular Epithelial Cells.

Magkrioti C, Antonopoulou G, Fanidis D, Pliaka V, Sakellaropoulos T, Alexopoulos L Int J Mol Sci. 2022; 23(13).

PMID: 35806457 PMC: 9267536. DOI: 10.3390/ijms23137452.


LPA and Autotaxin: Potential Drug Targets in Asthma?.

Georas S Cell Biochem Biophys. 2021; 79(3):445-448.

PMID: 34331220 PMC: 8551058. DOI: 10.1007/s12013-021-01023-7.

References
1.
Kihara Y, Mizuno H, Chun J . Lysophospholipid receptors in drug discovery. Exp Cell Res. 2014; 333(2):171-177. PMC: 4408218. DOI: 10.1016/j.yexcr.2014.11.020. View

2.
Li D, Liu H, Li Y, Yang M, Qu C, Zhang Y . Identification of suitable endogenous control genes for quantitative RT-PCR analysis of miRNA in bovine solid tissues. Mol Biol Rep. 2014; 41(10):6475-80. DOI: 10.1007/s11033-014-3530-x. View

3.
Huang L, Fu P, Patel P, Harijith A, Sun T, Zhao Y . Lysophosphatidic acid receptor-2 deficiency confers protection against bleomycin-induced lung injury and fibrosis in mice. Am J Respir Cell Mol Biol. 2013; 49(6):912-22. PMC: 3931116. DOI: 10.1165/rcmb.2013-0070OC. View

4.
Swaney J, Chapman C, Correa L, Stebbins K, Bundey R, Prodanovich P . A novel, orally active LPA(1) receptor antagonist inhibits lung fibrosis in the mouse bleomycin model. Br J Pharmacol. 2010; 160(7):1699-713. PMC: 2936842. DOI: 10.1111/j.1476-5381.2010.00828.x. View

5.
Crystal R, Bitterman P, Mossman B, Schwarz M, Sheppard D, Almasy L . Future research directions in idiopathic pulmonary fibrosis: summary of a National Heart, Lung, and Blood Institute working group. Am J Respir Crit Care Med. 2002; 166(2):236-46. DOI: 10.1164/rccm.2201069. View